Herantis Pharma Plc announced the election of Hilde Furberg to the Herantis Board of Directors, effective 15 April 2021. Mrs. Furberg is a former European Head of Rare Disease Europe/General Manager and Senior Vice President Rare Diseases EMEA at Genzyme/Sanofi Genzyme. Hilde was also the General Manager at Pharmalink and Baxter Healthcare.